{"id":3473,"date":"2020-04-28T18:33:21","date_gmt":"2020-04-28T23:33:21","guid":{"rendered":"https:\/\/www.hmf-law.com\/news\/class-action-lawsuit-alleges-eisai-arena-hid-cancer-risk-of-belviq-weight-loss-drug\/"},"modified":"2025-10-13T11:40:21","modified_gmt":"2025-10-13T16:40:21","slug":"class-action-lawsuit-alleges-eisai-arena-hid-cancer-risk-of-belviq-weight-loss-drug","status":"publish","type":"post","link":"https:\/\/www.hmf-law.com\/es\/news\/class-action-lawsuit-alleges-eisai-arena-hid-cancer-risk-of-belviq-weight-loss-drug\/","title":{"rendered":"Una demanda colectiva alega que Eisai y Arena ocultaron el riesgo de c\u00e1ncer del adelgazante Belviq"},"content":{"rendered":"<p>Eisai Inc. y Arena Pharmaceuticals, fabricantes de los f\u00e1rmacos <a href=\"https:\/\/www.hmf-law.com\/es\/belviq\/\">Belviq y Belviq XR (lorcaserina)<\/a>, se enfrentan a una demanda colectiva en la que se alega que estos medicamentos para adelgazar aumentan el riesgo de c\u00e1ncer de los pacientes que los utilizan. La demanda, presentada en marzo ante el Tribunal de Distrito de EE.UU. en White Plains, Nueva York, solicita la condici\u00f3n de demanda colectiva en nombre de los pacientes que utilizaron Belviq para perder peso y fueron diagnosticados de c\u00e1ncer. <!--more--><\/p>\n<p>Belviq fue aprobado por la Food and Drug Administration en 2012 para ayudar a los pacientes a perder peso junto con dieta y ejercicio. En el momento en que Belviq recibi\u00f3 la aprobaci\u00f3n de la FDA, la agencia expres\u00f3 su preocupaci\u00f3n por los estudios previos a la aprobaci\u00f3n, que suger\u00edan que el medicamento para adelgazar causaba un mayor riesgo de c\u00e1ncer en animales de laboratorio. Aunque Eisai aleg\u00f3 que estos mayores riesgos de c\u00e1ncer no se presentar\u00edan en humanos, la FDA orden\u00f3 a la empresa realizar un estudio de seguridad de cinco a\u00f1os para determinar si los usuarios de Belviq corr\u00edan riesgo de desarrollar c\u00e1ncer.  <\/p>\n<p>En febrero de 2020, la FDA recibi\u00f3 <a href=\"https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/safety-clinical-trial-shows-possible-increased-risk-cancer-weight-loss-medicine-belviq-belviq-xr\">los resultados del estudio de cinco a\u00f1os sobre el c\u00e1ncer realizado con Belviq<\/a>. El estudio, que realiz\u00f3 un seguimiento de 12.000 pacientes tratados con Belviq o con placebo, revel\u00f3 que los usuarios de Belviq ten\u00edan m\u00e1s probabilidades de desarrollar varios tipos de c\u00e1ncer, entre ellos c\u00e1ncer de p\u00e1ncreas, c\u00e1ncer colorrectal y c\u00e1ncer de pulm\u00f3n. <\/p>\n<p>En respuesta a estos resultados, la FDA orden\u00f3 a Eisai retirar Belviq del mercado. Eisai cumpli\u00f3 la orden ese mismo mes y retir\u00f3 Belviq y Belviq XR del mercado debido al mayor riesgo de c\u00e1ncer descubierto en el estudio de la empresa. La FDA aconsej\u00f3 a los pacientes que utilizaban Belviq o Belviq XR que dejaran de tomarlos inmediatamente y que consultaran a su m\u00e9dico sobre tratamientos alternativos para perder peso.  <\/p>\n<h2>Eisai se enfrenta a demandas de usuarios de Belviq con c\u00e1ncer<\/h2>\n<p>En marzo de 2020, una mujer de Nueva York present\u00f3 una demanda colectiva contra Eisai. La demanda alega que la farmac\u00e9utica sigui\u00f3 fabricando y vendiendo Belviq a pesar de las claras pruebas de que el medicamento para adelgazar pod\u00eda aumentar el riesgo de c\u00e1ncer de los pacientes que lo utilizaban. En la demanda tambi\u00e9n se nombra a Arena Pharmaceuticals (el fabricante original de Belviq) y CVS Pharmacy como demandantes en el caso.  <\/p>\n<p>Seg\u00fan la demanda, la FDA rechaz\u00f3 inicialmente la solicitud de Arena para que se aprobara la venta de Belviq en Estados Unidos debido a unas pruebas que mostraban que el f\u00e1rmaco aumentaba el riesgo de c\u00e1ncer en animales de laboratorio. Aunque Belviq fue aprobado cuando Arena y Eisai volvieron a presentar el medicamento en 2012, la demanda alega que la FDA nunca habr\u00eda aprobado la venta de Belviq en EE.UU. si los fabricantes hubieran sido honestos con la agencia sobre los riesgos de c\u00e1ncer de este medicamento. <\/p>\n<p>La demanda contra Eisai y Arena pretende obtener la condici\u00f3n de acci\u00f3n colectiva en nombre de los pacientes que compraron Belviq. La demanda acusa a las dos empresas de incumplimiento de la garant\u00eda impl\u00edcita, pr\u00e1cticas comerciales enga\u00f1osas, publicidad falsa, enriquecimiento injusto y fraude en relaci\u00f3n con la comercializaci\u00f3n y venta de Belviq. <\/p>\n<h2>Los usuarios de Belviq con c\u00e1ncer pueden presentar una demanda<\/h2>\n<p>Si usted o un ser querido fueron tratados con Belviq o Belviq XR y se les diagnostic\u00f3 c\u00e1ncer -incluido c\u00e1ncer de p\u00e1ncreas, c\u00e1ncer colorrectal o c\u00e1ncer de pulm\u00f3n-, es posible que re\u00fanan los requisitos para presentar una demanda y recibir una indemnizaci\u00f3n. El primer paso para emprender acciones legales es hablar con un abogado experto en responsabilidad civil por productos defectuosos que pueda asesorarle sobre sus derechos legales y guiarle en los primeros pasos para presentar una demanda. <\/p>\n<p>Si desea obtener m\u00e1s informaci\u00f3n sobre las demandas por Belviq presentadas contra Eisai y saber si re\u00fane los requisitos para presentar una demanda, p\u00f3ngase en contacto con los abogados de Hissey, Mulderig &amp; Friend para programar una consulta legal gratuita. Puede ponerse en contacto con nosotros llamando al n\u00famero gratuito <a href=\"tel:1-866-210-5686\">1-866-210-5686<\/a>, o rellenando nuestro <a href=\"https:\/\/www.hmf-law.com\/es\/contact\/\">formulario de evaluaci\u00f3n gratuita de casos<\/a> situado en la parte superior de esta p\u00e1gina. <\/p>\n","protected":false},"excerpt":{"rendered":"<p>Eisai Inc. y Arena Pharmaceuticals, fabricantes de los f\u00e1rmacos Belviq [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":3176,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":false,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[62],"tags":[],"class_list":["post-3473","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-belviq-es"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Demanda colectiva sobre los riesgos de c\u00e1ncer de Belviq | Hissey, Mulderig &amp; Friend<\/title>\n<meta name=\"description\" content=\"Una demanda colectiva alega que Eisai y Arena ocultaron los riesgos de c\u00e1ncer de los medicamentos para adelgazar Belviq y Belviq XR (lorcaserina).\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.hmf-law.com\/es\/news\/class-action-lawsuit-alleges-eisai-arena-hid-cancer-risk-of-belviq-weight-loss-drug\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Demanda colectiva sobre los riesgos de c\u00e1ncer de Belviq | Hissey, Mulderig &amp; Friend\" \/>\n<meta property=\"og:description\" content=\"Una demanda colectiva alega que Eisai y Arena ocultaron los riesgos de c\u00e1ncer de los medicamentos para adelgazar Belviq y Belviq XR (lorcaserina).\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.hmf-law.com\/es\/news\/class-action-lawsuit-alleges-eisai-arena-hid-cancer-risk-of-belviq-weight-loss-drug\/\" \/>\n<meta property=\"og:site_name\" content=\"Hissey, Mulderig &amp; Friend\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/hisseymulderigfriend\/\" \/>\n<meta property=\"article:published_time\" content=\"2020-04-28T23:33:21+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-10-13T16:40:21+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.hmf-law.com\/wp-content\/uploads\/2020\/03\/Belviq.jpg\" \/>\n<meta name=\"author\" content=\"Hissey, Mulderig &amp; Friend\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/www.hmf-law.com\/wp-content\/uploads\/2020\/03\/Belviq.jpg\" \/>\n<meta name=\"twitter:creator\" content=\"@HMFLawFirm\" \/>\n<meta name=\"twitter:site\" content=\"@HMFLawFirm\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.hmf-law.com\\\/es\\\/news\\\/class-action-lawsuit-alleges-eisai-arena-hid-cancer-risk-of-belviq-weight-loss-drug\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.hmf-law.com\\\/es\\\/news\\\/class-action-lawsuit-alleges-eisai-arena-hid-cancer-risk-of-belviq-weight-loss-drug\\\/\"},\"author\":{\"name\":\"Hissey, Mulderig &amp; Friend\",\"@id\":\"https:\\\/\\\/www.hmf-law.com\\\/es\\\/#\\\/schema\\\/person\\\/44c3790ecb3e582c81e85b16a18a81c8\"},\"headline\":\"Una demanda colectiva alega que Eisai y Arena ocultaron el riesgo de c\u00e1ncer del adelgazante Belviq\",\"datePublished\":\"2020-04-28T23:33:21+00:00\",\"dateModified\":\"2025-10-13T16:40:21+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.hmf-law.com\\\/es\\\/news\\\/class-action-lawsuit-alleges-eisai-arena-hid-cancer-risk-of-belviq-weight-loss-drug\\\/\"},\"wordCount\":771,\"publisher\":{\"@id\":\"https:\\\/\\\/www.hmf-law.com\\\/es\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.hmf-law.com\\\/es\\\/news\\\/class-action-lawsuit-alleges-eisai-arena-hid-cancer-risk-of-belviq-weight-loss-drug\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.hmf-law.com\\\/wp-content\\\/uploads\\\/2020\\\/04\\\/shutterstock_76852249-e1608127899212.jpg\",\"articleSection\":[\"Belviq\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.hmf-law.com\\\/es\\\/news\\\/class-action-lawsuit-alleges-eisai-arena-hid-cancer-risk-of-belviq-weight-loss-drug\\\/\",\"url\":\"https:\\\/\\\/www.hmf-law.com\\\/es\\\/news\\\/class-action-lawsuit-alleges-eisai-arena-hid-cancer-risk-of-belviq-weight-loss-drug\\\/\",\"name\":\"Demanda colectiva sobre los riesgos de c\u00e1ncer de Belviq | Hissey, Mulderig &amp; Friend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.hmf-law.com\\\/es\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.hmf-law.com\\\/es\\\/news\\\/class-action-lawsuit-alleges-eisai-arena-hid-cancer-risk-of-belviq-weight-loss-drug\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.hmf-law.com\\\/es\\\/news\\\/class-action-lawsuit-alleges-eisai-arena-hid-cancer-risk-of-belviq-weight-loss-drug\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.hmf-law.com\\\/wp-content\\\/uploads\\\/2020\\\/04\\\/shutterstock_76852249-e1608127899212.jpg\",\"datePublished\":\"2020-04-28T23:33:21+00:00\",\"dateModified\":\"2025-10-13T16:40:21+00:00\",\"description\":\"Una demanda colectiva alega que Eisai y Arena ocultaron los riesgos de c\u00e1ncer de los medicamentos para adelgazar Belviq y Belviq XR (lorcaserina).\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.hmf-law.com\\\/es\\\/news\\\/class-action-lawsuit-alleges-eisai-arena-hid-cancer-risk-of-belviq-weight-loss-drug\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.hmf-law.com\\\/es\\\/news\\\/class-action-lawsuit-alleges-eisai-arena-hid-cancer-risk-of-belviq-weight-loss-drug\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/www.hmf-law.com\\\/es\\\/news\\\/class-action-lawsuit-alleges-eisai-arena-hid-cancer-risk-of-belviq-weight-loss-drug\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.hmf-law.com\\\/wp-content\\\/uploads\\\/2020\\\/04\\\/shutterstock_76852249-e1608127899212.jpg\",\"contentUrl\":\"https:\\\/\\\/www.hmf-law.com\\\/wp-content\\\/uploads\\\/2020\\\/04\\\/shutterstock_76852249-e1608127899212.jpg\",\"width\":798,\"height\":798,\"caption\":\"At least a dozen lawsuits have been filed by Belviq users with cancer. More lawsuits are expected to be filed by lawyers involved in this litigation.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.hmf-law.com\\\/es\\\/news\\\/class-action-lawsuit-alleges-eisai-arena-hid-cancer-risk-of-belviq-weight-loss-drug\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inicio\",\"item\":\"https:\\\/\\\/www.hmf-law.com\\\/es\\\/inicio\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Una demanda colectiva alega que Eisai y Arena ocultaron el riesgo de c\u00e1ncer del adelgazante Belviq\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.hmf-law.com\\\/es\\\/#website\",\"url\":\"https:\\\/\\\/www.hmf-law.com\\\/es\\\/\",\"name\":\"Hissey, Mulderig & Friend\",\"description\":\"Un bufete de abogados de Austin, Texas, especializado en responsabilidad civil por productos defectuosos.\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.hmf-law.com\\\/es\\\/#organization\"},\"alternateName\":\"HM&F\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.hmf-law.com\\\/es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.hmf-law.com\\\/es\\\/#organization\",\"name\":\"Hissey, Mulderig &amp; Friend\",\"alternateName\":\"HM&F\",\"url\":\"https:\\\/\\\/www.hmf-law.com\\\/es\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/www.hmf-law.com\\\/es\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.hmf-law.com\\\/wp-content\\\/uploads\\\/2020\\\/12\\\/Hissey-Mulderig-Friend-Logo-Square-Horizontal.jpg\",\"contentUrl\":\"https:\\\/\\\/www.hmf-law.com\\\/wp-content\\\/uploads\\\/2020\\\/12\\\/Hissey-Mulderig-Friend-Logo-Square-Horizontal.jpg\",\"width\":1296,\"height\":936,\"caption\":\"Hissey, Mulderig &amp; Friend\"},\"image\":{\"@id\":\"https:\\\/\\\/www.hmf-law.com\\\/es\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/hisseymulderigfriend\\\/\",\"https:\\\/\\\/x.com\\\/HMFLawFirm\",\"https:\\\/\\\/www.instagram.com\\\/hmflawfirm\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/1878565\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.hmf-law.com\\\/es\\\/#\\\/schema\\\/person\\\/44c3790ecb3e582c81e85b16a18a81c8\",\"name\":\"Hissey, Mulderig &amp; Friend\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Demanda colectiva sobre los riesgos de c\u00e1ncer de Belviq | Hissey, Mulderig &amp; Friend","description":"Una demanda colectiva alega que Eisai y Arena ocultaron los riesgos de c\u00e1ncer de los medicamentos para adelgazar Belviq y Belviq XR (lorcaserina).","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.hmf-law.com\/es\/news\/class-action-lawsuit-alleges-eisai-arena-hid-cancer-risk-of-belviq-weight-loss-drug\/","og_locale":"es_ES","og_type":"article","og_title":"Demanda colectiva sobre los riesgos de c\u00e1ncer de Belviq | Hissey, Mulderig &amp; Friend","og_description":"Una demanda colectiva alega que Eisai y Arena ocultaron los riesgos de c\u00e1ncer de los medicamentos para adelgazar Belviq y Belviq XR (lorcaserina).","og_url":"https:\/\/www.hmf-law.com\/es\/news\/class-action-lawsuit-alleges-eisai-arena-hid-cancer-risk-of-belviq-weight-loss-drug\/","og_site_name":"Hissey, Mulderig &amp; Friend","article_publisher":"https:\/\/www.facebook.com\/hisseymulderigfriend\/","article_published_time":"2020-04-28T23:33:21+00:00","article_modified_time":"2025-10-13T16:40:21+00:00","og_image":[{"url":"https:\/\/www.hmf-law.com\/wp-content\/uploads\/2020\/03\/Belviq.jpg","type":"","width":"","height":""}],"author":"Hissey, Mulderig &amp; Friend","twitter_card":"summary_large_image","twitter_image":"https:\/\/www.hmf-law.com\/wp-content\/uploads\/2020\/03\/Belviq.jpg","twitter_creator":"@HMFLawFirm","twitter_site":"@HMFLawFirm","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.hmf-law.com\/es\/news\/class-action-lawsuit-alleges-eisai-arena-hid-cancer-risk-of-belviq-weight-loss-drug\/#article","isPartOf":{"@id":"https:\/\/www.hmf-law.com\/es\/news\/class-action-lawsuit-alleges-eisai-arena-hid-cancer-risk-of-belviq-weight-loss-drug\/"},"author":{"name":"Hissey, Mulderig &amp; Friend","@id":"https:\/\/www.hmf-law.com\/es\/#\/schema\/person\/44c3790ecb3e582c81e85b16a18a81c8"},"headline":"Una demanda colectiva alega que Eisai y Arena ocultaron el riesgo de c\u00e1ncer del adelgazante Belviq","datePublished":"2020-04-28T23:33:21+00:00","dateModified":"2025-10-13T16:40:21+00:00","mainEntityOfPage":{"@id":"https:\/\/www.hmf-law.com\/es\/news\/class-action-lawsuit-alleges-eisai-arena-hid-cancer-risk-of-belviq-weight-loss-drug\/"},"wordCount":771,"publisher":{"@id":"https:\/\/www.hmf-law.com\/es\/#organization"},"image":{"@id":"https:\/\/www.hmf-law.com\/es\/news\/class-action-lawsuit-alleges-eisai-arena-hid-cancer-risk-of-belviq-weight-loss-drug\/#primaryimage"},"thumbnailUrl":"https:\/\/www.hmf-law.com\/wp-content\/uploads\/2020\/04\/shutterstock_76852249-e1608127899212.jpg","articleSection":["Belviq"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/www.hmf-law.com\/es\/news\/class-action-lawsuit-alleges-eisai-arena-hid-cancer-risk-of-belviq-weight-loss-drug\/","url":"https:\/\/www.hmf-law.com\/es\/news\/class-action-lawsuit-alleges-eisai-arena-hid-cancer-risk-of-belviq-weight-loss-drug\/","name":"Demanda colectiva sobre los riesgos de c\u00e1ncer de Belviq | Hissey, Mulderig &amp; Friend","isPartOf":{"@id":"https:\/\/www.hmf-law.com\/es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.hmf-law.com\/es\/news\/class-action-lawsuit-alleges-eisai-arena-hid-cancer-risk-of-belviq-weight-loss-drug\/#primaryimage"},"image":{"@id":"https:\/\/www.hmf-law.com\/es\/news\/class-action-lawsuit-alleges-eisai-arena-hid-cancer-risk-of-belviq-weight-loss-drug\/#primaryimage"},"thumbnailUrl":"https:\/\/www.hmf-law.com\/wp-content\/uploads\/2020\/04\/shutterstock_76852249-e1608127899212.jpg","datePublished":"2020-04-28T23:33:21+00:00","dateModified":"2025-10-13T16:40:21+00:00","description":"Una demanda colectiva alega que Eisai y Arena ocultaron los riesgos de c\u00e1ncer de los medicamentos para adelgazar Belviq y Belviq XR (lorcaserina).","breadcrumb":{"@id":"https:\/\/www.hmf-law.com\/es\/news\/class-action-lawsuit-alleges-eisai-arena-hid-cancer-risk-of-belviq-weight-loss-drug\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.hmf-law.com\/es\/news\/class-action-lawsuit-alleges-eisai-arena-hid-cancer-risk-of-belviq-weight-loss-drug\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.hmf-law.com\/es\/news\/class-action-lawsuit-alleges-eisai-arena-hid-cancer-risk-of-belviq-weight-loss-drug\/#primaryimage","url":"https:\/\/www.hmf-law.com\/wp-content\/uploads\/2020\/04\/shutterstock_76852249-e1608127899212.jpg","contentUrl":"https:\/\/www.hmf-law.com\/wp-content\/uploads\/2020\/04\/shutterstock_76852249-e1608127899212.jpg","width":798,"height":798,"caption":"At least a dozen lawsuits have been filed by Belviq users with cancer. More lawsuits are expected to be filed by lawyers involved in this litigation."},{"@type":"BreadcrumbList","@id":"https:\/\/www.hmf-law.com\/es\/news\/class-action-lawsuit-alleges-eisai-arena-hid-cancer-risk-of-belviq-weight-loss-drug\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inicio","item":"https:\/\/www.hmf-law.com\/es\/inicio\/"},{"@type":"ListItem","position":2,"name":"Una demanda colectiva alega que Eisai y Arena ocultaron el riesgo de c\u00e1ncer del adelgazante Belviq"}]},{"@type":"WebSite","@id":"https:\/\/www.hmf-law.com\/es\/#website","url":"https:\/\/www.hmf-law.com\/es\/","name":"Hissey, Mulderig & Friend","description":"Un bufete de abogados de Austin, Texas, especializado en responsabilidad civil por productos defectuosos.","publisher":{"@id":"https:\/\/www.hmf-law.com\/es\/#organization"},"alternateName":"HM&F","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.hmf-law.com\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.hmf-law.com\/es\/#organization","name":"Hissey, Mulderig &amp; Friend","alternateName":"HM&F","url":"https:\/\/www.hmf-law.com\/es\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.hmf-law.com\/es\/#\/schema\/logo\/image\/","url":"https:\/\/www.hmf-law.com\/wp-content\/uploads\/2020\/12\/Hissey-Mulderig-Friend-Logo-Square-Horizontal.jpg","contentUrl":"https:\/\/www.hmf-law.com\/wp-content\/uploads\/2020\/12\/Hissey-Mulderig-Friend-Logo-Square-Horizontal.jpg","width":1296,"height":936,"caption":"Hissey, Mulderig &amp; Friend"},"image":{"@id":"https:\/\/www.hmf-law.com\/es\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/hisseymulderigfriend\/","https:\/\/x.com\/HMFLawFirm","https:\/\/www.instagram.com\/hmflawfirm\/","https:\/\/www.linkedin.com\/company\/1878565\/"]},{"@type":"Person","@id":"https:\/\/www.hmf-law.com\/es\/#\/schema\/person\/44c3790ecb3e582c81e85b16a18a81c8","name":"Hissey, Mulderig &amp; Friend"}]}},"jetpack_publicize_connections":[],"_links":{"self":[{"href":"https:\/\/www.hmf-law.com\/es\/wp-json\/wp\/v2\/posts\/3473","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.hmf-law.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.hmf-law.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.hmf-law.com\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.hmf-law.com\/es\/wp-json\/wp\/v2\/comments?post=3473"}],"version-history":[{"count":0,"href":"https:\/\/www.hmf-law.com\/es\/wp-json\/wp\/v2\/posts\/3473\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.hmf-law.com\/es\/wp-json\/wp\/v2\/media\/3176"}],"wp:attachment":[{"href":"https:\/\/www.hmf-law.com\/es\/wp-json\/wp\/v2\/media?parent=3473"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.hmf-law.com\/es\/wp-json\/wp\/v2\/categories?post=3473"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.hmf-law.com\/es\/wp-json\/wp\/v2\/tags?post=3473"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}